AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
On research in a small country - Basic research and its practical applications
Authors: Sela, M
Citation: M. Sela, On research in a small country - Basic research and its practical applications, EMBO REP, 2(8), 2001, pp. 642-643
An altered peptide ligand inhibits the activities of matrix metalloproteinase-9 and phospholipase C, and inhibits T cell interactions with VCAM-1 induced in vivo by a myasthenogenic T cell epitope
Authors: Faber-Elmann, A Grabovsky, V Dayan, M Sela, M Alon, R Mozes, E
Citation: A. Faber-elmann et al., An altered peptide ligand inhibits the activities of matrix metalloproteinase-9 and phospholipase C, and inhibits T cell interactions with VCAM-1 induced in vivo by a myasthenogenic T cell epitope, FASEB J, 15(1), 2001, pp. 187-194
Metastatic hypernephroma to the head and neck: Unusual case reports and review of the literature
Authors: Sabo, R Sela, M Sabo, G Herskovitz, P Feinmesser, R
Citation: R. Sabo et al., Metastatic hypernephroma to the head and neck: Unusual case reports and review of the literature, J OTOLARYNG, 30(3), 2001, pp. 140-144
Humoral and cellular immune responses to Copolymer 1 in multiple sclerosispatients treated with Copaxone (R)
Authors: Brenner, T Arnon, R Sela, M Abramsky, O Meiner, Z Riven-Kreitman, R Tarcik, N Teitelbaum, D
Citation: T. Brenner et al., Humoral and cellular immune responses to Copolymer 1 in multiple sclerosispatients treated with Copaxone (R), J NEUROIMM, 115(1-2), 2001, pp. 152-160
Copolymer 1 inhibits manifestations of graft rejection
Authors: Aharoni, R Teitelbaum, D Arnon, R Sela, M
Citation: R. Aharoni et al., Copolymer 1 inhibits manifestations of graft rejection, TRANSPLANT, 72(4), 2001, pp. 598-605
The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes
Authors: Paas-Rozner, M Sela, M Mozes, E
Citation: M. Paas-rozner et al., The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes, P NAS US, 98(22), 2001, pp. 12642-12647
Kindler syndrome complicated by squamous cell carcinoma of the hard palate: successful treatment with high-dose radiation therapy and granulocyte-macrophage colony-stimulating factor
Authors: Lotem, M Raben, M Zeltser, R Landau, M Sela, M Wygoda, M Tochner, ZA
Citation: M. Lotem et al., Kindler syndrome complicated by squamous cell carcinoma of the hard palate: successful treatment with high-dose radiation therapy and granulocyte-macrophage colony-stimulating factor, BR J DERM, 144(6), 2001, pp. 1284-1286
Cytokine profile and T cell adhesiveness to endothelial selectins: in vivoinduction by a myasthenogenic T cell epitope and immunomodulation by a dual altered peptide ligand
Authors: Faber-Elmann, A Grabovsky, V Dayan, M Sela, M Alon, R Mozes, E
Citation: A. Faber-elmann et al., Cytokine profile and T cell adhesiveness to endothelial selectins: in vivoinduction by a myasthenogenic T cell epitope and immunomodulation by a dual altered peptide ligand, INT IMMUNOL, 12(12), 2000, pp. 1651-1658
Inhibition of tumor growth by poly(ethylene glycol) derivatives of anti-ErbB2 antibodies
Authors: Hurwitz, E Klapper, LN Wilchek, M Yarden, Y Sela, M
Citation: E. Hurwitz et al., Inhibition of tumor growth by poly(ethylene glycol) derivatives of anti-ErbB2 antibodies, CANCER IMMU, 49(4-5), 2000, pp. 226-234
Streptococcus mutans in saliva of normal subjects and neck and head irradiated cancer subjects after consumption of honey
Authors: Sela, M Maroz, D Gedalia, I
Citation: M. Sela et al., Streptococcus mutans in saliva of normal subjects and neck and head irradiated cancer subjects after consumption of honey, J ORAL REH, 27(3), 2000, pp. 269-270
Structural components responsible for peptide antigenicity
Authors: Sela, M
Citation: M. Sela, Structural components responsible for peptide antigenicity, APPL BIOC B, 83(1-3), 2000, pp. 63-70
Specific inhibition of the reaction between a tumor-inhibitory antibody and the ErbB-2 receptor by a mimotope derived from a phage display library
Authors: Vaisman, N Nissim, A Klapper, LN Tirosh, B Yarden, Y Sela, M
Citation: N. Vaisman et al., Specific inhibition of the reaction between a tumor-inhibitory antibody and the ErbB-2 receptor by a mimotope derived from a phage display library, IMMUNOL LET, 75(1), 2000, pp. 61-67
Biochemical and clinical implications of the ErbB/HER signaling network ofgrowth factor receptors
Authors: Klapper, LN Kirschbaum, MH Sela, M Yarden, Y
Citation: Ln. Klapper et al., Biochemical and clinical implications of the ErbB/HER signaling network ofgrowth factor receptors, ADV CANC R, 77, 2000, pp. 25-79
Oral administration of a dual analog of two myasthenogenic T cell epitopesdown-regulates experimental autoimmune myasthenia gravis in mice
Authors: Paas-Rozner, M Dayan, M Paas, Y Changeux, JP Wirguin, I Sela, M Mozes, E
Citation: M. Paas-rozner et al., Oral administration of a dual analog of two myasthenogenic T cell epitopesdown-regulates experimental autoimmune myasthenia gravis in mice, P NAS US, 97(5), 2000, pp. 2168-2173
Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1
Authors: Aharoni, R Teitelbaum, D Leitner, O Meshorer, A Sela, M Arnon, R
Citation: R. Aharoni et al., Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1, P NAS US, 97(21), 2000, pp. 11472-11477
T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: Possible therapy for optic neuropathies
Authors: Kipnis, J Yoles, E Porat, Z Cohen, A Mor, F Sela, M Cohen, IR Schwartz, M
Citation: J. Kipnis et al., T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: Possible therapy for optic neuropathies, P NAS US, 97(13), 2000, pp. 7446-7451
c-Cbl is a suppressor of the Neu oncogene
Authors: Levkowitz, G Oved, S Klapper, LN Harari, D Lavi, S Sela, M Yarden, Y
Citation: G. Levkowitz et al., c-Cbl is a suppressor of the Neu oncogene, J BIOL CHEM, 275(45), 2000, pp. 35532-35539
Comparative genetics of nucleotide binding site-leucine rich repeat resistance gene homologues in the genomes of two dicotyledons: Tomato and Arabidopsis
Authors: Pan, QL Liu, YS Budai-Hadrian, O Sela, M Carmel-Goren, L Zamir, D Fluhr, R
Citation: Ql. Pan et al., Comparative genetics of nucleotide binding site-leucine rich repeat resistance gene homologues in the genomes of two dicotyledons: Tomato and Arabidopsis, GENETICS, 155(1), 2000, pp. 309-322
Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2
Authors: Klapper, LN Waterman, H Sela, M Yarden, Y
Citation: Ln. Klapper et al., Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2, CANCER RES, 60(13), 2000, pp. 3384-3388
Binding of random copolymers of three amino acids to class II MHC molecules
Authors: Fridkis-Hareli, M Aharoni, R Teitelbaum, D Arnon, R Sela, M Strominger, JL
Citation: M. Fridkis-hareli et al., Binding of random copolymers of three amino acids to class II MHC molecules, INT IMMUNOL, 11(5), 1999, pp. 635-641
Specific vaccines against autoimmune diseases
Authors: Sela, M
Citation: M. Sela, Specific vaccines against autoimmune diseases, CR AC S III, 322(11), 1999, pp. 933-938
The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors
Authors: Klapper, LN Glathe, S Vaisman, N Hynes, NE Andrews, GC Sela, M Yarden, Y
Citation: Ln. Klapper et al., The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors, P NAS US, 96(9), 1999, pp. 4995-5000
Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1
Authors: Teitelbaum, D Arnon, R Sela, M
Citation: D. Teitelbaum et al., Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1, P NAS US, 96(7), 1999, pp. 3842-3847
Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basicprotein by T cell receptor antagonism in addition to major histocompatibility complex blocking
Authors: Aharoni, R Teitelbaum, D Arnon, R Sela, M
Citation: R. Aharoni et al., Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basicprotein by T cell receptor antagonism in addition to major histocompatibility complex blocking, P NAS US, 96(2), 1999, pp. 634-639
Binding motifs of copolymer 1 to multiple sclerosis- and rheumatoid arthritis-associated HLA-DR molecules
Authors: Fridkis-Hareli, M Neveu, JM Robinson, RA Lane, WS Gauthier, L Wucherpfennig, KW Sela, M Strominger, JL
Citation: M. Fridkis-hareli et al., Binding motifs of copolymer 1 to multiple sclerosis- and rheumatoid arthritis-associated HLA-DR molecules, J IMMUNOL, 162(8), 1999, pp. 4697-4704
Risultati: 1-25 | 26-28